Related Experiment Video
Updated: May 3, 2026
12:18
Assessing Biofilm Dispersal in Murine Wounds
Published on: August 7, 2021
4.3K
Clinically Addressing Biofilm in Chronic Wounds
Christopher Attinger1, Randy Wolcott2
1Division of Wound Healing, Georgetown University Hospital , Washington, District of Columbia.
Advances in Wound Care
|February 15, 2014
Summary
Chronic wounds often harbor bacterial and fungal biofilms, hindering healing. Identifying specific microbes with polymerase chain reaction (PCR) enables targeted treatments to improve chronic wound care.
Area of Science:
- Wound Healing Research
- Microbiology
- Clinical Therapeutics
Background:
- Chronic wounds stall in the inflammatory healing phase.
- Biofilms, composed of bacteria and fungi, are present in over 90% of chronic wounds.
- Biofilms impede effective wound healing and resist treatment.
Purpose of the Study:
- To address the challenge of biofilm in chronic wound management.
- To explore methods for tailoring therapeutic approaches to specific biofilm characteristics.
- To define strategies for overcoming biofilm resistance.
Main Methods:
- Utilizing polymerase chain reaction (PCR) to identify microbial components within biofilms.
- Implementing a regular debridement schedule to disrupt biofilm formation.
- Directing therapeutic maneuvers based on PCR identification of specific bacteria and fungi.
Main Results:
- Biofilms develop resistance to therapies within 48-96 hours.
- Repeated disruption forces biofilm reattachment, increasing susceptibility to antibiotics and host defenses.
- PCR-guided identification allows for targeted topical antibiotics and biocides, enhancing debridement efficacy.
Conclusions:
- Biofilms in chronic wounds perpetuate inflammation and delay healing.
- Combining debridement with PCR-based microbial identification facilitates targeted biofilm elimination.
- PCR-directed adjunctive therapies show promise in improving chronic wound biofilm management.
